High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
Souad Assaad, Virginie Avrillon, Marie‐Line Fournier, Bénédicte Mastroïanni, Bruno Russias, Aurélie Swalduz, Philippe A. Cassier, Lauriane Eberst, Marie-Pierre Steineur, Marianne Kazes, M. Pérol, Anne-Sophie Michallet, Philippe Rey, Anne-Sophie Erena-Penet, Astrid Morel, Mehdi Brahmi, Armelle Dufresne, Olivier Trédan, Gisèle Chvetzoff, Jérôme Fayette, Christelle de la Fouchardière, Isabelle Ray‐Coquard, Thomas Bachelot, Pierre Saintigny, Mayeul Tabutin, Aurélien Dupré, Emmanuelle Nicolas‐Virelizier, Amine Belhabri, Pierre-Eric Roux, Christine Fuhrmann, F. Pilleul, Alexandre Basle, Amine Bouhamama, Christelle Galvez, Andrée-Laure Herr, Julien Gautier, Sylvie Chabaud, Philippe Zrounba, David Pérol, Jean‐Yves Blay
Topics & Concepts
MedicineInternal medicineCoronavirus disease 2019 (COVID-19)PneumoniaCancerSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Retrospective cohort studyGastroenterologyRespiratory systemReal-time polymerase chain reactionDiseaseInfectious disease (medical specialty)GeneBiochemistryChemistryCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing